Filing Alert: Synexis Chapter 11

Synexis LLC, an Overland Park, KS-based developer of continuous pathogen control technology, filed for Chapter 11 protection on November 18, 2026, in the U.S...

Synexis LLC, an Overland Park, KS-based developer of continuous pathogen control technology, filed for Chapter 11 protection on Nov. 18 in the U.S. Bankruptcy Court for the District of Delaware.

The company attributes its distress to a history of operating losses, which stemmed from research and development, intellectual property and other development costs that outpaced revenue. It funded operations primarily through equity investment and, more recently, through $7.05 million in 14% senior secured notes issued under a March 2026 note purchase agreement, at least $4.875 million of which are held by insiders.

After receiving substantially all of the note proceeds, the company had approximately $5.8 million in cash on its balance sheet as of April 30, 2026, but that cushion wore away over the following months. Revenue fell well below budget, while expected proceeds from inventory sales and the liquidation of raw materials were delayed, as was an approximately $2.75 million Employee Retention Credit claim still pending with the IRS. By the petition date, cash had declined to approximately $100,000, leaving the company with insufficient liquidity to maintain operations.

The company intends to pursue a sale and a plan addressing the disposition of the estate. Its investment banker, Brown, Gibbons, Lang & Company Securities, began marketing the business on Sept. 11, 2026. To keep operating while that process plays out, the company is seeking approval of a $1.5 million DIP facility from Bryan Marsal or his designee, along with use of cash collateral.

The company reports $22.2 million in assets and $10.9 million in liabilities. The filing indicates that there will be funds available for distribution to unsecured creditors. The case number is 26-11846.


Key Parties

Counsel:

Signatories: